Press Releases

News Dec 1, 2015 CardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure SAN DIEGO — Dec. 1, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, intends to

News Nov 16, 2015 CardioCell CEO Presents at the World Congress of Regenerative Medicine & Stem Cell – Shanghai 2015 SHANGHAI, CHINA – WORLD CONGRESS OF REGENERATIVE MEDICINE & STEM CELL 2015 – Nov. 16, 2015 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that

News Oct 28, 2015 CardioCell CEO Presents at BIO-Europe 2015 MUNICH, GERMANY – BIO-EUROPE 2015 – Oct. 28, 2015 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, announces a presentation by CEO Sergey

News Oct 21, 2015 CardioCell Board Members and Clinical Trial Leads Collaborate on Peer-Reviewed Paper Published in the Journal of Cardiovascular Medicine SAN DIEGO — Oct. 21, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for

News Sep 1, 2015 CardioCell Scientific Advisory Board Chair Presents at the Stem Cells & Regenerative Medicine Congress 2015 WASHINGTON, D.C. – STEM CELLS & REGENERATIVE MEDICINE CONGRESS 2015 – Sept. 1, 2015 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary

News Nov 20, 2014 University of Pennsylvania Doses First Patient in Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy PHILADELPHIA — Nov. 20, 2014 — CardioCell LLC, a Stemedica Cell Technologies Inc.